Characterization of immunostimulatory CpG-rich sequences from different Bifidobacterium species

Applied and Environmental Microbiology

Volumn 76, Issue 9, 2010, Pages 2846-2855

  Ménard, Odile ^a   Gafa, Valérie ^b   Kapel, Nathalie ^a,c   Rodriguez, Bertrand ^a   Butel, Marie José ^a   Waligora Dupriet, Anne Judith ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SEQUENCES; BENEFICIAL EFFECTS; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; CHEMOATTRACTANTS; DOT-BLOTTING; GENOME SEQUENCES; HIGH FREQUENCY; IN-SILICO; LACTIC ACID BACTERIA; PCR AMPLIFICATION; PRETERM INFANTS; PROBIOTICS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR ALPHA;

AMPLIFICATION; BACTERIOLOGY; BODY FLUIDS; DNA; LACTIC ACID; MACROPHAGES; ORGANIC ACIDS;

GENES;

BACTERIAL DNA; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; IMMUNOLOGICAL ADJUVANT; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BACTERIUM; DNA; GENOME; HETEROGENEITY; POLYMERASE CHAIN REACTION; PROTEIN; TUMOR;

ARTICLE; BIFIDOBACTERIUM; CHEMISTRY; CPG ISLAND; GENETICS; HUMAN; INFANT; METABOLISM; NUCLEOTIDE SEQUENCE;

ADJUVANTS, IMMUNOLOGIC; BASE SEQUENCE; BIFIDOBACTERIUM; CPG ISLANDS; DINUCLEOSIDE PHOSPHATES; DNA, BACTERIAL; HUMANS; INFANT; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM;

EID: 77951569874     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01714-09     Document Type: Article

References (57)

1. Alfaleh, K., and D. Bassler. 2008. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 23: CD005496.
2. Amrouche, T., Y. Boutin, G. Prioult, and I. Fliss. 2006. Effects of bifidobacteria! cytoplasm, cell wall and exopolysaccharide on mouse lymphocyte proliferation and cytokine production. Int. Dairy J. 16:70-80.
3. Ashkar, A. A., and K. L. Rosenthal. 2002. Toll-like receptor 9, CpG DNA and innate immunity. Curr. MoI. Med. 2:545-556.
4. Butel, M. J., N. Roland, A. Hibert, F. Popot, A. Favre, A. C. Tessèdre, M. Bensaada, A. Rimbault, and O. Szylit. 1998. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J. Med. Microbiol. 47:391-399.
5. Chung, C. T., S. L. Memela, and R. H. Miller. 1989. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sei. U. S. A. 86:2172-2175.
6. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
7. Forchielli, M. L., and W. A. Walker. 2005. The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93(Suppl. 1):S41-S48.
8. Gao, J. J., V. Diesl, T. Wittmann, D. C. Morrison, J. L. Ryan, S. N. Vogel, and M. T. Follettie. 2002. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J. Leukoc. Biol. 72:1234-1245.
9. Ghadimi, D., R. Folster-Holst, M. de Vrese, P. Winkler, K. J. Heller, and J. Schrezenmeir. 2008. Effects of probiotic bacteria and their genomic DNA on THl/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213:677-692.
10. Harmsen, H. J., A. C. Wildeboer-Veloo, G. C. Raangs, A. A. Wagendorp, N. KIlJn, J. G. Bindels, and G. W. Welling. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30:61-67.
11. He, F., H. Morita, A. C. Ouwehand, M. Hosoda, M. Hiramatsu, J. Kurisaki, E. Isolauri, Y. Benno, and S. Salminen. 2002. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol. Immunol. 46:781-785.
12. Hessle, C., B. Andersson, and A. E. Wold. 2000. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect. Immun. 68:35813586.
13. Hoarau, C., C. Lagaraine, L. Martin, F. Velge-Roussel, and Y. Lebranchu. 2006. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 117:696-702.
14. Iliev, I. D., H. Kitazawa, T. Shimosato, S. Katoh, H. Morita, F. He, M. Hosoda, and T. Saito. 2005. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynudeotide pattern. Cell. Microbiol. 7:403-414.
15. Iliev, I. D., M. Tohno, D. Kurosaki, T. Shimosato, F. He, M. Hosoda, T. Saito, and H. Kitazawa. 2008. Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice. Scand. J. Immunol. 67:370-376.
16. Inoue, Y., N. Iwabuchi, J. Z. Xiao, T. Yaeshima, and K. Iwatsuki. 2009. Suppressive effects of Bifidobacterium breve strain M-16V on T-helper type 2 immune responses in a murine model. Biol. Pharm. Bull. 2:760-763.
17. Karlin, S-, J. Mrazek, and A. M. Campbell. 1997. Compositional biases of bacterial genomes and evolutionary implications. J. Bacteriol. 179:38993913.
18. Karlsson, H., C. Hessle, and A. Rudin. 2002. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 70:6688-6696.
19. Kim, H., S. Y. Lee, and G. E. Ji. 2005. Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice. Biotechnol. Lett. 27:1361-1367.
20. Kim, J. F., H. Jeong, D. S. Yu, S. H. Choi, C. G. Hur, M. S. Park, S. H. Yoon, D. W. Kim, G. E. Ji, H. S. Park, and T. K. Oh. 2009. Genome sequence of the probiotic bacterium Bifidobacterium animalis subsp. lactis AD011. J. Bacteriol. 191:678-679.
21. Kitagaki, K., V. V. Jain, T. R. Businga, I. Hussain, and J. N. Kline. 2002. Immunomodulatory effects of CpG oligodeoxynucleotides on established Th2 responses. Clin. Diagn. Lab. Immunol. 9:1260-1269.
22. 22. Kitazawa, H., H. Watanabe, T. Shimosato, Y. Kawai, T. Itoh, and T. Saito. 2003. Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbmeckii ssp. bulgaricus NIAI B6. Int. J. Food Microbiol. 85:11-21. (Pubitemid 37329364)
23. Klinman, D. M. 2004. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4:249-258.
24. Kok, R. G., A. de Waal, F. Schut, G. W. Welling, G. Weenk, and K. J. Hellingwerf. 1996. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl. Environ. Microbiol. 62:3668-3672.
25. Krieg, A. M. 2000. The role of CpG motifs in innate immunity. Curr. Opin. Immunol. 12:35-43.
26. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
27. Lammers, K. M., P. Brigidi, B. Vitali, P. Gionchetti, F. Rizzello, E. Caramelli, D. Matteuzzi, and M. Campieri. 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-I and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 38:165-172.
28. Lee, J. H., V. N. Karamychev, S. A. Kozyavkin, D. Mills, A. R Pavlov, N. V. Pavlova, N. N. Polouchine, P. M. Richardson, V. V. Shakhova, A. I. Slesarev, B. Weimer, and D. J. O'Sullivan. 2008. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth. BMC Genomics 9:247.
29. Lenert, P., A. K. Yi, A. M. Krieg, L. L. Stunz, and R. F. Ashman. 2003. Inhibitory oligonucleotides block the induction of AP-I transcription factor by stimulatory CpG oligonucleotides in B cells. Antisense Nucleic Acid Drug Dev. 13:143-150.
30. Li, Y., X. Qu, H. Yang, L. Kang, Y. Xu, B. Bai, and W. Song. 2005. Bifidobacteria DNA induces murine macrophages activation in vitro. Cell. Mol. Immunol. 2:473-478.
31. Medina, M., E. Izquierdo, S. Ennahar, and Y. Sanz. 2007. Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin. Exp. Immunol. 150:531538.
32. Menard, O., M. J. Butel, V. Gaboriau-Routhiau, and A. J. Waligora-Dupriet. 2008. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl. Environ. Microbiol. 74:660-666.
33. 33. Menard, S., C. Candalh, J. C. Bambou, K. Terpend, N. Cerf-Bensussan, and M. Heyman. 2004. Lactic acid bacteria secrete metabolites retaining antiinflammatory properties after intestinal transport. Gut 53:821-828. (Pubitemid 38662131)
34. Menard, S., D. Laharie, C. Asensio, T. Vidal-Martinez, C. Candalh, A. Rullier, F. Zerbib, F. Megraud, T. Matysiak-Budnik, and M. Heyman. 2005. Bifidobacterium breve and Streptococcus thermophilus secretion products en- hance T helper 1 immune response and intestinal barrier in mice. Exp. Biol. Med. (Maywood) 230:749-756.
35. Mullié, C., M. F. Odou, E. Singer, M. B. Romond, and D. Izard. 2003. Multiplex FCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. FEMS Microbiol. Lett. 222:129-136.
36. Neujahr, D. C., C. F. Reich, and D. S. Pisetsky. 1999. Immunostimulatory properties of genomic DNA from different bacterial species. Immunobiology 200:106-119.
37. Ohno, H., S. Tsunemine, Y. Isa, M. Shimakawa, and H. Yamamura. 2005. Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice. Biol. Pharm. Bull. 28:1462-1466.
38. 38. Penders, J., E. E. Stobberingh, P. A. van den Brandt, and C. Thijs. 2007. The role of the intestinal microbiota in the development of atopic disorders. Allergy 62:1223-1236. (Pubitemid 47537504)
39. 39. Peter, M., K. Bode, G. B. Lipford, F. Eberle, K. Heeg, and A. H. Dalpke. 2008. Characterization of suppressive oligodeoxynucieotides that inhibit Toll-like receptor-9-mediated activation of innate immunity. Immunology 123:118-128. (Pubitemid 350256002)
40. Picard, C., J. Fioramonti, A. Francois, T. Robinson, F. Neant, and C. Matuchansky. 2005. Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22:495512.
41. Round, J. L., R. M. O'Connell, and S. K. Mazmanian. 6 December 2009. Coordination of tolerogenic immune responses by the commensal microbiota. J. Autoimmun. 34:J220-J225. [Epub ahead of print.]
42. Satokari, R., T. Gronroos, K. Laitinen, S. Salminen, and E. Isolauri. 2009. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett. Appl. Microbiol. 48:8-12.
43. Schell, M. A., M. Karmirantzou, B. Snel, D. Vilanova, B. Berger, G. Pessi, M. C. Zwahlen, F. Deslere, P. Bork, M. Delley, R. D. Pridmore, and F. Arigoni. 2002. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl. Acad. Sci. U. S. A. 99:14422-14427.
44. Sela, D. A., J. Chapman, A. Adeuya, J. H. Kim, F. Chen, T. R. Whitehead, A. Lapidus, D. S. Rokhsar, C. B. Lebrilla, J. B. German, N. P. Price, P. M. Richardson, and D. A. Mills. 2008. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U. S. A. 105:18964-18969.
45. Shimosato, T., H. Kitazawa, S. Katoh, M. Tohno, I. D. Iliev, C. Nagasawa, T. Kimura, Y. Kawai, and T. Saito. 2005. Augmentation of T(H)-I type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling. Biochem. Biophys. Res. Commun. 326:782787.
46. Smits, H. H., A. J. van Beelen, C. Hessle, R. Westland, E. de Jong, E. Soeteman, A. Wold, E. A. Wierenga, and M. L. Kapsenberg. 2004. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and 1L-27 expression and enhanced ThI development. Eur. J. Immunol. 34:1371-1380.
47. Suau, A., R. Bonnet, M. Sutren, J. J. Godon, G. R. Gibson, M. D. Collins, and J. Dore. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65:4799-4807.
48. Sudo, N., Y. Alba, N. Oyama, X. N. Yu, M. Matsunaga, Y. Koga, and C. Kubo. 2004. Dietary nucleic acid and intestinal microbiota synergistically promote a shift in the Thl/Th2 balance toward Thl-skewed immunity. Int. Arch. Allergy Immunol. 135:132-135.
49. Sugai, T., M. Mori, M. Nakazawa, M. Ichino, T. Naruto, N. Kobayashi, Y. Kobayashi, M. Minami, and S. Yokota. 2005. A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Thl/Th2 immune response in diphtheria-tetanus-pertussis vaccine. Vaccine 23:54505456.
50. Takahashi, N., H. Kitazawa, N. Iwabuchi, J. Z. Xiao, K. Miyaji, K. Iwatsuki, and T. Saito. 2006. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Qin. Exp. Immunol. 145:130-138.
51. Takahashi, N., H. Kitazawa, N. Iwabuchi, J. Z. Xiao, K. Miyaji, K. Iwatsuki, and T. Saito. 2006. Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Thl/Th2 balance in a murine model. Biosci. Biotechnol. Biochem. 70:2013-2017.
52. Takahashi, N., H. Kitazawa, T. Shimosato, N. Iwabuchi, J. Z. Xiao, K. Iwatsuki, S. Kokubo, and T. Saito. 2006. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro. FEMS Immunol. Med. Microbiol. 46:461-469.
53. Talati, A. J., H. J. Kim, Y. I. Kim, A. K. Yi, and B. K. English. 2008. Role of bacterial DNA in macrophage activation by group B streptococci. Microbes Infect. 10:1106-1113.
54. Tross, D., L. Petrenko, S. Klaschik, Q. Zhu, and D. M. Klinman. 2009. Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. Mol. Immunol. 46:1557-2564.
55. Watson, J. L., and D. M. McKay. 2006. The immunophysiological impact of bacterial CpG DNA on the gut. Qin. Chim. Acta 364:1-11.
56. Young, S. L., M. A. Simon, M. A. Baird, G. W. Tannock, R. Bibiloni, K. Spencely, J. M. Lane, P. Fitzharris, J. Crane, I. Town, E. Addo-Yobo, C. S. Murray, and A. Woodcock. 2004. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin. Diagn. Lab. Immunol. 11:686-690.
57. 57. Zhu, H., F. Qu, and L. H. Zhu. 1993. Isolation of genomic DNAs from plants, fungi and bacteria using benzyl chloride. Nucleic Acids Res. 21:5279-5280. (Pubitemid 23342547)